Antimicrobial Revision in Persistent Febrile Neutropenia

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
Febrile neutropenia is often seen in patients with hematologic malignancies who receive cytotoxic chemotherapy. These patients are usually placed on posaconazole prophylaxis upon starting chemotherapy. If an episode of febrile neutropenia occurs, generally an anti-pseudomonal beta lactam, like cefepime or piperacillin-tazobactam, is initiated. In patients who continue to fever on these agents, the optimal method of antimicrobial revision has yet to be determined.
Epistemonikos ID: a024f145989e5d4d5cde9991db84ad7b080ccb7c
First added on: Feb 19, 2024